EU Approval for Vision Restoring Chip Raises Questions About Access and Equity The European Union's medical device regulator has approved Science Corporation's PRIMA device, a cutting edge technology that restores vision lost from age related macular degeneration (AMD).
The device uses a hybrid of silicon chips and living cells to transmit a view of the world via camera equipped glasses.
Millions worldwide suffer from AMD, with an estimated 10 million people in the United States alone living with some form of macular degeneration.